InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-75.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Brigido Stephen, Pres., Functional Regeneration. Insider active across 1 company, notably Celularity Inc. In total, 10 reports have been recorded. Activity tracked since 13 April 2023. The latest transaction was disclosed on 13 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations10 total
821 shares0Class A Common StockSEC:0001493152-26-016834
821 shares0Class A Common StockSEC:0001493152-26-016834:0
820 shares0Class A Common StockSEC:0001641172-25-004821:0
268 shares@ US$1.642.4% of flowClass A Common StockSEC:0001641172-25-004821:1
10,000 shares0Class A Common StockSEC:0001493152-25-007614:0
268 shares@ US$4.116.3% of flowClass A Common StockSEC:0001493152-24-014944:0
32,720 shares@ US$0.43480.7% of flowClass A Common StockSEC:0001493152-24-007471:0
2,683 shares@ US$0.714110.6% of flowClass A Common StockSEC:0000899243-23-011346:0
200,000 sharesClass A Common StockSEC:0000899243-23-005917:0
32,809 sharesClass A Common StockSEC:0000899243-22-015908:0
10 of 10 declarations
About Brigido Stephen
Stephen Brigido is the President of Functional Regeneration at Celularity Inc. He oversees regeneration and innovation initiatives within the company. His role is essential in developing new solutions.
